Your Shopping Cart
No Items
Commentary by: Eric Murphy, Managing Director, Global Healthcare Services
Kauffman Hall reported in its 2022 M&A in Review report that the fourth quarter of 2022 was the most active healthcare mergers and acquisitions quarter transformative transactions since the beginning of the pandemic. A total of 17 transactions were announced in the fourth quarter, with four transactions occurring where the smaller party of the transaction has annual revenues of $1 billion+. The average smaller party size of announced transactions reached an all-time high of $852 million, well above the previous record of $619 million in 2021.
2022 Recap
In total for 2022, there were 53 announced transactions, up from 49 in 2022. Total transacted revenue topped $45 billion for 2022, up from $32 billion in 2021. Total transacted revenue hasn’t exceeded $40 billion since 2017. The trend continued in 2022 where less transactions were announced, but the size of the transactions are well-above averages seen in years 2020 and prior. The smaller size party annual revenue has grown annually by 12% over the past 10 years.
Source: Kaufman, Hall & Associates, LLC
Posted on 02/13/2023 at 10:45 AM
All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.
